Establishment Labs Holdings (ESTA) Cash from Operations (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Cash from Operations came in at 4310000.0 in Q1 2026, up 79.2% year-on-year from 2405082.12 in Q1 2025, and down 2560.49% quarter-over-quarter from 162000.0 in Q4 2025.
Establishment Labs Holdings (ESTA) Cash from Operations (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Cash from Operations history runs 10 years deep, the most recent figure standing at 4310000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 79.2% year-over-year to 4310000.0 in Q1 2026; TTM through Mar 2026 was 34475000.0, a 49.37% increase from a year earlier, with the FY2025 full-year figure at 50890000.0, up 13.03% from the prior year.
- Cash from Operations eased to 4310000.0 in Q1 2026 per ESTA's latest filing, from 162000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 162000.0 in Q4 2025 and bottomed at 31511000.0 in Q3 2023.
- The 5-year median for Cash from Operations is 14016000.0 (2022), against an average of 14964411.76.
- Across the five-year window, Cash from Operations tumbled 1291.89% in 2022 and soared 99.22% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 14016000.0 in 2022, then soared by 41.87% to 8148000.0 in 2023, then slumped by 154.65% to 20749000.0 in 2024, then surged by 99.22% to 162000.0 in 2025, then sank by 2560.49% to 4310000.0 in 2026.
- Per Business Quant, the three latest ESTA Cash from Operations figures stand at 4310000.0 (Q1 2026), 162000.0 (Q4 2025), and 11250000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | -4.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.31 Mn |
| Mar 31, 2026 | -4.31 Mn |
| Dec 31, 2025 | -162,000.00 |
| Dec 31, 2025 | -162,000.00 |
| Sep 30, 2025 | -11.25 Mn |
| Sep 30, 2025 | -11.25 Mn |
| Jun 30, 2025 | -18.75 Mn |
| Jun 30, 2025 | -18.75 Mn |
| Mar 31, 2025 | -20.73 Mn |
| Mar 31, 2025 | -20.73 Mn |
| Dec 31, 2024 | -20.75 Mn |
| Dec 31, 2024 | -20.75 Mn |
| Sep 30, 2024 | -12.46 Mn |
| Sep 30, 2024 | -12.46 Mn |
| Jun 30, 2024 | -14.15 Mn |
| Jun 30, 2024 | -14.15 Mn |
| Mar 31, 2024 | -11.15 Mn |
| Mar 31, 2024 | -11.15 Mn |
| Dec 31, 2023 | -8.15 Mn |
| Dec 31, 2023 | -8.15 Mn |